Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study

Leonardo De Luca, Paolo Calabrò, Fabio Chirillo, Cristina Rolfo, Alberto Menozzi, Piera Capranzano, Maurizio Menichelli, Elisa Nicolini, Ciro Mauro, Carlo Trani, Francesco Versaci, Fabrizio Tomai, Giuseppe Musumeci, Carlo Di Mario, Martino Pepe, Sergio Berti, Carlo Cernetti, Plinio Cirillo, Diego Maffeo, Giuseppe TalanasMarco Ferlini, Marco Contarini, Valerio Lanzilotti, Marino Scherillo, Giuseppe Tarantini, Simone Muraglia, Roberta Rossini, Leonardo Bolognese

Research output: Contribution to journalArticle

Abstract

N/A
Original languageEnglish
Pages (from-to)N/A-N/A
JournalClinical Cardiology
DOIs
Publication statusPublished - 2022

Keywords

  • P2Y12 inhibitor
  • acute coronary syndrome
  • bleeding
  • cangrelor
  • cardiac artery disease
  • real-world evidence

Fingerprint

Dive into the research topics of 'Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study'. Together they form a unique fingerprint.

Cite this